Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Operating Leases (2019 - 2025)

Entera Bio has reported Operating Leases over the past 7 years, most recently at $490000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 80.15% year-over-year to $490000.0, compared with a TTM value of $490000.0 through Dec 2025, up 80.15%, and an annual FY2025 reading of $490000.0, up 80.15% over the prior year.
  • Operating Leases came in at $490000.0 for Q4 2025, up from $41000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $490000.0 in Q4 2025 to a low of $3000.0 in Q3 2022.
  • Median Operating Leases over the past 5 years was $183000.0 (2021), compared with a mean of $201611.1.
  • The sharpest move saw Operating Leases tumbled 98.04% in 2022, then surged 13300.0% in 2023.
  • Over 5 years, Operating Leases stood at $302000.0 in 2021, then plummeted by 99.01% to $3000.0 in 2022, then soared by 12900.0% to $390000.0 in 2023, then crashed by 30.26% to $272000.0 in 2024, then skyrocketed by 80.15% to $490000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Operating Leases are $490000.0 (Q4 2025), $41000.0 (Q3 2025), and $9000.0 (Q2 2025).